Integrating pathways of Parkinson's disease in a molecular interaction map.
about
Global implementation of genomic medicine: We are not aloneMerging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's diseaseBioinformatics Mining and Modeling Methods for the Identification of Disease Mechanisms in Neurodegenerative DisordersBiomarkers of postoperative delirium and cognitive dysfunctionHigh-affinity glutamate transporters in chronic pain: an emerging therapeutic targetSTON: exploring biological pathways using the SBGN standard and graph databasesMaking sense of big data in health research: Towards an EU action planIs dementia research ready for big data approaches?The COPD Knowledge Base: enabling data analysis and computational simulation in translational COPD research.Integration and Visualization of Translational Medicine Data for Better Understanding of Human Diseases.Interdisciplinary approach towards a systems medicine toolbox using the example of inflammatory diseases.Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP(+)Eryptosis as a marker of Parkinson's diseaseSystems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson's disease.Network Analysis of a Comprehensive Knowledge Repository Reveals a Dual Role for Ceramide in Alzheimer's Disease.Comparing Alzheimer's and Parkinson's diseases networks using graph communities structurePDON: Parkinson's disease ontology for representation and modeling of the Parkinson's disease knowledge domain.Using prior knowledge from cellular pathways and molecular networks for diagnostic specimen classification.Using the Gene Ontology to Annotate Key Players in Parkinson's DiseaseNur77 exacerbates PC12 cellular injury in vitro by aggravating mitochondrial impairment and endoplasmic reticulum stress.From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicineA LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis.Leigh map: A novel computational diagnostic resource for mitochondrial disease.New insights on the mitochondrial proteome plasticity in Parkinson's disease.MINERVA-a platform for visualization and curation of molecular interaction networks.Novel Approaches in Astrocyte Protection: from Experimental Methods to Computational Approaches.The Impact of Mathematical Modeling in Understanding the Mechanisms Underlying Neurodegeneration: Evolving Dimensions and Future Directions.Network-Guided Key Gene Discovery for a Given Cellular Process.Precision medicine for disease modification in Parkinson disease.Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity.A systems biology-led insight into the role of the proteome in neurodegenerative diseases.Irisflorentin improves α-synuclein accumulation and attenuates 6-OHDA-induced dopaminergic neuron degeneration, implication for Parkinson's disease therapy.Selective aptamer-based control of intraneuronal signalingComputational systems biology approaches for Parkinson's disease.Repositioning drugs by targeting network modules: a Parkinson's disease case study.Convergent pathways in Parkinson's disease.Molecular Role of Ca2+ and Hard Divalent Metal Cations on Accelerated Fibrillation and Interfibrillar Aggregation of α-Synuclein.Exploring autophagy with Gene Ontology.A roadmap towards personalized immunology.Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology.
P2860
Q24658586-C2D58DC4-985D-49D2-82F1-637E31F330E4Q26773485-635C6075-98CA-4680-B6C4-83C257FAE08DQ26774418-AAB85C2A-2C4C-4F1D-A134-4B5283D96501Q26830796-9861BB36-8EBB-43AA-9462-A99D7F56D513Q27020953-CE7F0F79-9832-4634-BE99-F5D5D4F200E4Q28589481-CE327358-E27C-4D79-B64C-C821242EF3EAQ28597362-30C2EF03-E478-4C1B-8400-2DB0561CEDA5Q28648089-A2A2D553-0514-4E92-8F4D-5746450C6F75Q30874144-61C95502-55F2-4AB3-9F53-08680A870031Q31116335-6F8EA555-688C-47D2-B91D-647DFD93188EQ33675239-BFA9D4E9-CEEC-4CEB-A49B-06496EE69277Q33720121-46425305-1407-47F8-8189-B788FB088A88Q34585744-F86F8885-D7B1-430F-90BE-0D2CF911CB0DQ35200884-1A43A729-69A8-416A-97EB-B7CEEE40FB34Q35915842-4DFE374F-6FF0-43D0-ACB3-114AF846ED04Q35943528-178B9BE9-634A-4628-885B-9D245D06C5BAQ36086743-A4644281-1A64-471F-8D94-7E4246070FCEQ36910040-BB207328-EB0E-40E3-B1E4-0C829D9E459EQ36978820-D52C2C8E-2279-432B-98EE-87E0C047CFA5Q37294245-1496EF1D-F421-49D3-BC02-9D40F08FD745Q37320493-C4412193-764C-4DA2-A872-6310A0C539E9Q37341837-8B8C3D49-6C7C-4567-9CFA-BE311C237ADEQ37696444-2891EAA6-F5E7-4509-AB65-0E020DFE5486Q38452561-DF7857FF-0EFE-4AB0-80C3-7662AC7FAB32Q38671214-21D9DC2D-D799-48CA-B199-43CAC63C510FQ38709211-04EAF3DB-DF51-4289-8079-A3DA952336EFQ38773606-DE057ACC-3757-4658-B393-04F9A1E3DD7FQ38991241-B9B2DA73-F15F-4908-81CA-9026827C9FDBQ39096323-DCD7682D-442A-4C8F-88AC-B5913BD140A1Q39320908-0A376303-672D-431C-A82C-D0F7BB70E39FQ39540210-48B1A618-00F0-43F5-B078-E830C87E4550Q41369321-7011079B-82D8-4CBA-9BE0-179A05CA48A3Q42212423-0EB87AEA-D168-4D80-B501-1D5F9553A9CCQ45943481-99392C2D-9297-4BD4-8FE5-98EFFA8D1E95Q47135602-F47F1AF7-E8A6-49EC-BFDE-6DF2B25953C9Q47612330-E15AAB30-89B0-41D0-9CFF-A282035ECA7CQ48138690-640CD21D-7C18-4D8E-9419-727DA57C0D1BQ49888739-97F9454C-AC22-468C-89CD-948C4EA0BA44Q50104991-4086BF15-9FD5-49F0-8488-6D65049EF1D5Q51760905-4FF120FF-565F-46E1-B05F-2FDAF85358AC
P2860
Integrating pathways of Parkinson's disease in a molecular interaction map.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Integrating pathways of Parkinson's disease in a molecular interaction map.
@en
type
label
Integrating pathways of Parkinson's disease in a molecular interaction map.
@en
prefLabel
Integrating pathways of Parkinson's disease in a molecular interaction map.
@en
P2093
P2860
P50
P1476
Integrating pathways of Parkinson's disease in a molecular interaction map.
@en
P2093
Akihiko Kodama
Hiroaki Kitano
Kazuhiro A Fujita
Manuel Buttini
Nico Diederich
Paul M A Antony
Reinhard Schneider
Samik Ghosh
Serge Eifes
Wiktor Jurkowski
P2860
P2888
P304
P356
10.1007/S12035-013-8489-4
P50
P577
2013-07-07T00:00:00Z
2014-02-01T00:00:00Z
P5875
P6179
1031017148